Photo of Jason M. Rednour

Jason Rednour is a partner in the Corporate practice of Paul Hastings and a member of the firm’s Private Equity and Mergers and Acquisitions practice groups. 

Mr. Rednour’s practice focuses primarily on representing private equity funds and private equity-backed companies in equity financings and mergers and acquisitions.

Mr. Rednour has represented clients in matters in various industries, with particular emphasis on assisting private equity funds in the acquisition and sale of software and other technology companies.

On December 2, 2020, with a bipartisan voice vote, the House approved Senate Bill S. 945 to enact the Holding Foreign Companies Accountable Act (the “Act”).

[1] The Senate previously approved the bill by unanimous vote and both the Senate and House expect it to be signed into law by the President. Once implemented by

Palo Alto – Paul Hastings LLP, a leading global law firm, announced today that the firm served as legal advisor to Jasper Therapeutics, Inc. (Jasper Therapeutics) in its agreement to merge with Amplitude Healthcare Acquisition Corporation, a special purpose acquisition company (SPAC).

The merger will result in Jasper Therapeutics becoming a publicly listed company. The